{'output': [['Atara Biotherapeutics', 'ORG', 'Announce', 'underwritten public offering', 'FIN_INSTRUMENT'], ['Atara Biotherapeutics', 'ORG', 'Raise', '$100,000,000', 'ECON_INDICATOR'], ['Atara Biotherapeutics', 'ORG', 'Grant', '30-day option', 'NONE'], ['Atara Biotherapeutics', 'ORG', 'Grant', 'additional $15,000,000', 'ECON_INDICATOR'], ['Atara Biotherapeutics', 'ORG', 'Sell', 'shares of common stock', 'FIN_INSTRUMENT'], ['Underwriters', 'ORG', 'Act', 'joint book-running managers', 'NONE'], ['Underwriters', 'ORG', 'Grant', '30-day option', 'NONE'], ['Underwriters', 'ORG', 'Purchase', 'additional $15,000,000', 'ECON_INDICATOR'], ['Atara Biotherapeutics', 'ORG', 'Operate_In', 'Nasdaq', 'EXCH'], ['Atara Biotherapeutics', 'ORG', 'File', 'shelf registration statement', 'NONE'], ['Atara Biotherapeutics', 'ORG', 'Include', 'base prospectus', 'NONE'], ['SEC', 'ORG/REG', 'Be', 'effective', 'NONE'], ['Atara Biotherapeutics', 'ORG', 'Grant', 'underwriters', 'ORG'], ['Underwriters', 'ORG', 'Purchase', 'shares of common stock', 'FIN_INSTRUMENT'], ['Atara Biotherapeutics', 'ORG', 'Disclose', 'final terms', 'NONE'], ['Atara Biotherapeutics', 'ORG', 'Has', 'press release', 'NONE'], ['Atara Biotherapeutics', 'ORG', 'Contain', 'forward-looking statements', 'NONE'], ['Atara Biotherapeutics', 'ORG', 'Relate_To', 'market conditions', 'NONE'], ['Atara Biotherapeutics', 'ORG', 'Relate_To', 'satisfaction of customary closing conditions', 'NONE'], ['Atara Biotherapeutics', 'ORG', 'Disclaim', 'intention or obligation to update or revise', 'NONE'], ['Atara Biotherapeutics', 'ORG', 'Relate_To', 'November 9, 2017', 'DATE'], ['Atara Biotherapeutics', 'ORG', 'Relate_To', 'quarterly report on Form 10-Q', 'NONE'], ['Atara Biotherapeutics', 'ORG', 'Relate_To', 'Risk Factors', 'NONE'], ['Atara Biotherapeutics', 'ORG', 'Has', 'Investors', 'NONE'], ['Atara Biotherapeutics', 'ORG', 'Has', 'Media', 'NONE'], ['Investors', 'ORG', 'Contact', 'John Craighead', 'PERSON'], ['John Craighead', 'PERSON', 'Role', 'Atara Biotherapeutics', 'ORG'], ['Investors', 'ORG', 'Contact', 'Steve Klass', 'PERSON'], ['Steve Klass', 'PERSON', 'Role', 'Burns McClellan', 'ORG'], ['Media', 'ORG', 'Contact', 'Justin Jackson', 'PERSON'], ['Justin Jackson', 'PERSON', 'Role', 'Burns McClellan', 'ORG'], ['Atara Biotherapeutics', 'ORG', 'Be', 'leading T-cell immunotherapy company', 'NONE'], ['Atara Biotherapeutics', 'ORG', 'Develop', 'novel treatments', 'NONE'], ['Atara Biotherapeutics', 'ORG', 'Treat', 'patients', 'NONE'], ['Atara Biotherapeutics', 'ORG', 'With', 'cancer', 'CONCEPT'], ['Atara Biotherapeutics', 'ORG', 'With', 'autoimmune', 'CONCEPT'], ['Atara Biotherapeutics', 'ORG', 'With', 'viral diseases', 'CONCEPT']]}